title: Editorial: diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseases.
authors.affiliation: Inflammatory Bowel Disease Unit, Department of Gastroenterology, The Alfred Hospital, Melbourne, Vic., Australia.
authors.forename: K M
authors.initials: KM
authors.lastname: Taylor
authors.affiliation: Inflammatory Bowel Disease Unit, Department of Gastroenterology, The Alfred Hospital, Melbourne, Vic., Australia. m.sparrow@alfred.org.au.
authors.forename: M P
authors.initials: MP
authors.lastname: Sparrow
mesh_terms: D003920:Diabetes Mellitus / Q000453:epidemiology*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008297:Male
chemical_list: D007155:Immunologic Factors